Sort by
Refine Your Search
-
Listed
-
Country
-
Employer
- Harvard University
- Nanyang Technological University
- University of Sydney
- King's College London
- National University of Singapore
- University of Birmingham
- Indiana University
- Monash University
- University of British Columbia
- University of Maryland, Baltimore
- University of Michigan
- Trinity College Dublin
- University of Oslo
- Zintellect
- City of Hope
- Northeastern University
- SINGAPORE INSTITUTE OF TECHNOLOGY (SIT)
- TAIPEI MEDICAL UNIVERSITY (TMU)
- University of Beira Interior
- University of Birmingham;
- University of California, Los Angeles
- University of Kansas Medical Center
- Carnegie Mellon University
- Cedars Sinai Medical Center
- Cellular and Molecular Therapeutics Branch, NHLBI, NIH
- Center for Biologics Evaluation and Research (CBER)
- Cold Spring Harbor Laboratory
- Georgetown University
- Macquarie University
- Nottingham Trent University
- QUEENS UNIVERSITY BELFAST
- Queen's University Belfast
- Shenzhen Bay Laboratory
- The University of Edinburgh;
- The University of Tokyo
- UCL;
- UNIVERSITY OF HELSINKI
- UNIVERSITY OF SURREY
- UNIVERSITY OF SYDNEY
- University College London
- University of Canterbury
- University of Denver
- University of Gloucestershire;
- University of Hull;
- University of Maryland School of Medicine, Baltimore
- University of North Carolina at Chapel Hill
- University of Oxford
- University of Sheffield
- University of Tennessee Medical Center at Knoxville
- University of Texas Rio Grande Valley
- University of Texas at Austin
- Virginia Tech
- Yeshiva University
- eQuest
- Łukasiewicz PORT
- 45 more »
- « less
-
Field
-
The Signature Research Programme in Neuroscience and Behavioural Disorders (“NBD”) is focused on understanding the structure and function of the nervous system, and the neural mechanisms underlying
-
of Neurology provides evaluation, treatment, and care for patients suffering from a wide range of neurological disorders including stroke, epilepsy, multiple sclerosis, Parkinson’s disease, amyotrophic lateral
-
About the position We invite applications for a 6‑month position in our project on cell-based therapy for inherited bleeding disorders. The position is part of an ongoing project funded by the Norwegian
-
the group of Prof. Teresa Carlomagno at the University of Birmingham. The research group studies the structural and functional mechanisms of proteins, including intrinsically disordered proteins, membrane
-
About the opportunity The Postdoctoral Research Fellow will lead and support preclinical neuroscience research investigating the interactions between sleep, circadian biology, and binge eating disorder
-
careers working with eating/weight disorders or adolescent behavioral health. This full-time position will involve approximately 50% research and 50% clinical intervention (therapy/assessment) delivered in
-
disordered proteins, nucleic acids and their complexes by integrative structural biology. The laboratory uses and develops state-of-the-art Nuclear Magnetic Resonance Spectroscopy (NMR) methods as a major
-
disease and other related disorders is to generate new and bold ideas that have a global impact. With this in mind, Fondation Alzheimer and the Global Brain Health Institute launched the French Alzheimer’s
-
the cellular and molecular pathways disrupted in brain disorders such as schizophrenia and autism, by utilizing recent advances in genetics and genomics. We are developing and applying tools to understand how
-
disorders. Working with children and young people, parents, schools, health professionals and community partners, the programme combines evidence-based interventions with co-production, training and research